BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rosenfeld G, Greenup AJ, Round A, Takach O, Halparin L, Saadeddin A, Ho JK, Lee T, Enns R, Bressler B. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World J Gastroenterol 2016; 22(36): 8211-8218 [PMID: 27688663 DOI: 10.3748/wjg.v22.i36.8211]
URL: https://www.wjgnet.com/1007-9327/full/v22/i36/8211.htm
Number Citing Articles
1
Chenthan Krishnakumar, Ashwin N. Ananthakrishnan, Brendan M. Boyle, Anne M. Griffiths, Neal S. LeLeiko, David R. Mack, James F. Markowitz, Joel R. Rosh, Cary G. Sauer, Thomas D. Walters, Erin Bonkowski, Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan. Early Change in Fecal Calprotectin Predicts One‐Year Outcome in Children Newly Diagnosed With Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition 2022; 74(1): 72 doi: 10.1097/MPG.0000000000003291
2
Barry D Kyle, Terence A Agbor, Shajib Sharif, Usha Chauhan, John Marshall, Smita L S Halder, Stephen Ip, Waliul I Khan. Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy ResultsJournal of the Canadian Association of Gastroenterology 2021; 4(2): 84 doi: 10.1093/jcag/gwaa009
3
Satwik Motaganahalli, Lauren Beswick, Danny Con, Daniel R. van Langenberg. Faecal calprotectin delivers on convenience, cost reduction and clinical decision‐making in inflammatory bowel disease: a real‐world cohort studyInternal Medicine Journal 2019; 49(1): 94 doi: 10.1111/imj.14027
4
Wei Zhang, Chiew Hsia Wong, Mallory Chavannes, Tima Mohammadi, Greg Rosenfeld. Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel diseaseBMJ Open 2019; 9(4): e027043 doi: 10.1136/bmjopen-2018-027043
5
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitisPLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
6
Waqqas Afif, Bernie Sattin, Dorota Dajnowiec, Reena Khanna, Cynthia H. Seow, Martin Williamson, Kinda Karra, Yanli Wang, Long-long Gao, Brian Bressler. Ustekinumab Therapeutic Drug Monitoring—Impact on Clinical Practice: A Multicenter Cross-Sectional Observational TrialDigestive Diseases and Sciences 2022; 67(7): 3148 doi: 10.1007/s10620-021-07173-1
7
Karoline Freeman, Brian H Willis, Hannah Fraser, Sian Taylor-Phillips, Aileen Clarke. Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracyBMJ Open 2019; 9(3): e027428 doi: 10.1136/bmjopen-2018-027428
8
Katarzyna Lewandowska, Olga Ciepiela. The correlation between the concentration of faecal calprotectin and markers of inflammation in children with gastrointestinal disordersDiagnostyka Laboratoryjna 2017; 53(2): 91 doi: 10.5604/01.3001.0013.7968
9
S. P. Jerkic, F. Michel, H. Donath, E. Herrmann, R. Schubert, M. Rosewich, S. Zielen. Calprotectin as a New Sensitive Marker of Neutrophilic Inflammation in Patients with Bronchiolitis ObliteransMediators of Inflammation 2020; 2020: 1 doi: 10.1155/2020/4641585
10
Agnieszka Wierzbicka, Artur Uździcki. A new uses of calprotectin as an inflammation biomarkerDiagnostyka Laboratoryjna 2023; 58(4): 158 doi: 10.5604/01.3001.0053.5970